Luotea Oyj
17.3.2026 18:00:00 CET | Globenewswire | Press release
Transfer of Luotea Plc’s own shares
Transfer of Luotea Plc’s own shares
Luotea Plc
Stock exchange release
17 March 2026 at 7:00 p.m.
Transfer of Luotea Plc’s own shares
Luotea Plc has, based on the decision of the Extraordinary General Meeting held on 4 December 2025, transferred 5,943 shares to the members of the Board of Directors of Luotea Plc as part of the Board remuneration. This transfer relates to the remuneration of the board members who commenced their term on 31 December 2025.
The share transfer price is EUR 2,40 which is the volume weighted average quotation of the share on 12 March 2026. After the transfer, Luotea holds 560,960 of its own shares.
LUOTEA PLC
Heikki Eskola
General Counsel
More information
Heikki Eskola, tel. +358 50 586 5907
Luotea is a real estate service company that provides comprehensive solutions throughout the entire lifecycle of properties, integrating energy efficiency and data-driven technologies. Luotea’s services enhance property value and create the best possible conditions for property users. Our offering includes a wide range of advanced property maintenance, technical, and consulting services, as well as cleaning and support services.
Luotea operates in Finland and Sweden. In 2025, the company’s revenue totaled €346 million, and it employs approximately 5,000 people. Luotea is listed on Nasdaq Helsinki.
Distribution:
Nasdaq Helsinki
Media
www.luotea.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Oma Säästöpankki Oyj7.10.2026 20:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of S-Bank Plc in Oma Savings Bank Plc has exceeded 90 percent
Oma Säästöpankki Oyj7.10.2026 19:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Parkanon Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
Zealand Pharma7.10.2026 19:13:53 CEST | Press release
Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes
ALK Abello7.10.2026 19:01:45 CEST | Press release
ALK upgrades its full-year outlook on strong tablet sales
ALK Abello7.10.2026 19:01:45 CEST | Pressemeddelelse
ALK opjusterer forventningerne til 2026 på baggrund af stærkt tabletsalg
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom